Factors of primary and secondary sulfonylurea failure in type 2 diabetic subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors of primary and secondary sulfonylurea failure in type 2 diabetic subjects

Published:2017-05-04 Issue:12 Volume:9 Page:1091-1099
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Wang Huaiqing¹,Ren Qian¹,Han Xueyao¹,Chen Jing¹,Zhou Lingli¹,Chen Yingli¹,Ji Linong¹

Affiliation:

1. Department of Endocrinology and Metabolism; Peking University People's Hospital, Peking University Diabetes Center; Beijing China

Funder

National High Technology Research and Development Program

Beijing Science and Technology Committee Funding

Guangzhou Zhongyi Pharmaceutical

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12542/fullpdf

Reference31 articles.

1. Standards of medical care in diabetes - 2017;American Diabetes Association;Diabetes Care,2017

2. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group;Simonson;Diabetes Care,1997

4. Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide;Satoh;Diabetes Res Clin Pract,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?;American Journal of Cardiovascular Drugs;2023-09-08

2. Organ fat in Latino youth at risk for type 2 diabetes;Pediatric Diabetes;2022-01-19

3. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus;Diabetes Research and Clinical Practice;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3